Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids

Thyroid cancerBrafOrganoids
Written By Aleks

H. Lasolle, A. Schiavo, A. Tourneur, P. Gillotay, B. de F. da Fonseca, L. Ceolin, O. Monestier, B. Aganahi, L. Chomette, M. M. L. Kizys, L. Haenebalcke, T. Pieters, S. Goossens, J. Haigh, V. Detours, A. L. S. Maia, S. Costagliola, and M. Romitti, Oncogene 1–16 (2023) doi:10.1038/s41388-023-02889-y.

Aleks
Previous

The olfactory receptor olfr78 promotes differentiation of enterochromaffin cells in the mouse colon
Next

Progress Toward and Challenges Remaining for Thyroid Tissue Regeneration